Source: Frontiers in Cellular and Infection Microbiology. Unidade: ICB
Subjects: MICROBIOLOGIA, ESCHERICHIA COLI, ANTIBIÓTICOS, VARIAÇÃO GENÉTICA, FENÓTIPOS, GENÓTIPOS, GENOMAS, AMINOGLICOSÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Agustina et al. Co-occurrence of NDM-5 and RmtB in a clinical isolate of Escherichia coli belonging to CC354 in Latin America. Frontiers in Cellular and Infection Microbiology, v. 11, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2021.654852. Acesso em: 19 out. 2024.APA
Costa, A., Espinosa, R. F., Gaudenzi, F., Lincopan, N., Araujo, B. F., Ghiglione, B., et al. (2021). Co-occurrence of NDM-5 and RmtB in a clinical isolate of Escherichia coli belonging to CC354 in Latin America. Frontiers in Cellular and Infection Microbiology, 11, 1-6. doi:10.3389/fcimb.2021.654852NLM
Costa A, Espinosa RF, Gaudenzi F, Lincopan N, Araujo BF, Ghiglione B, Gutkind G, Conza JD. Co-occurrence of NDM-5 and RmtB in a clinical isolate of Escherichia coli belonging to CC354 in Latin America [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-6.[citado 2024 out. 19 ] Available from: https://doi.org/10.3389/fcimb.2021.654852Vancouver
Costa A, Espinosa RF, Gaudenzi F, Lincopan N, Araujo BF, Ghiglione B, Gutkind G, Conza JD. Co-occurrence of NDM-5 and RmtB in a clinical isolate of Escherichia coli belonging to CC354 in Latin America [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-6.[citado 2024 out. 19 ] Available from: https://doi.org/10.3389/fcimb.2021.654852